Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ocean Biomedical Inc (OCEA)

Ocean Biomedical Inc (OCEA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 60,289
  • Shares Outstanding, K 34,649
  • Annual Sales, $ 0 K
  • Annual Income, $ -960 K
  • 60-Month Beta 1.64
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade OCEA with:

Options Overview Details

View History
  • Implied Volatility 60.81% ( -60.70%)
  • Historical Volatility 132.38%
  • IV Percentile 6%
  • IV Rank 3.54%
  • IV High 1,101.05% on 02/15/24
  • IV Low 22.60% on 09/15/23
  • Put/Call Vol Ratio 0.29
  • Today's Volume 247
  • Volume Avg (30-Day) 198
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 9,409
  • Open Int (30-Day) 10,589

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2501 +39.19%
on 04/25/24
2.6300 -33.84%
on 04/10/24
-0.7300 (-29.55%)
since 04/09/24
3-Month
0.5300 +228.30%
on 02/22/24
7.7900 -77.66%
on 03/05/24
+1.1900 (+216.36%)
since 02/09/24
52-Week
0.5200 +234.62%
on 02/07/24
12.0800 -85.60%
on 05/23/23
-4.1800 (-70.61%)
since 05/09/23

Most Recent Stories

More News
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:OCEA),(NASDAQ:LVTX),(NYSE:MRK),(NYSE:ABBV) EQNX::TICKER_END

OCEA : 1.7400 (-0.57%)
ONCY : 1.2400 (+5.08%)
ONC.TO : 1.69 (+4.32%)
LVTX : 3.11 (+0.97%)
MRK : 130.23 (+0.52%)
ABBV : 160.40 (-0.03%)
The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:PFE),(NASDAQ:OCEA),(NYSE:NVS),(NASDAQ:RLAY) EQNX::TICKER_END

ONCY : 1.2400 (+5.08%)
ONC.TO : 1.69 (+4.32%)
PFE : 28.18 (-0.32%)
OCEA : 1.7400 (-0.57%)
NVS : 100.21 (+0.61%)
RLAY : 6.31 (-3.07%)
The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028

/PRNewswire/ -- Metastatic breast cancer is the advanced stage of breast cancer, including cases wherein cancer has spread to the other parts of the body from...

ONC.TO : 1.69 (+4.32%)
ONCY : 1.2400 (+5.08%)
PFE : 28.18 (-0.32%)
OCEA : 1.7400 (-0.57%)
NVS : 100.21 (+0.61%)
RLAY : 6.31 (-3.07%)
Ocean Biomedical (NASDAQ: OCEA) Receives U.S. Patent Approval Notice for New Malaria Treatment

Ocean Biomedical, Inc. (NASDAQ: OCEA) is engaged as a biopharmaceutical company, which is focused on the development and commercialization of

OCEA : 1.7400 (-0.57%)
Why Shares of Ocean Biomedical Soared Thursday

The stock doubled in price over the course of the day.

OCEA : 1.7400 (-0.57%)
Ocean Biomedical (NASDAQ: OCEA) Skyrockets 324% After Announcing Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors Shown to Kill Glioblastoma & Melanoma Cancer Cells

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a Rhode Island-based biopharmaceutical company, which is focused on the development and commercialization of

OCEA : 1.7400 (-0.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Ocean Biomedical Inc. is a biopharma company which involved in development and commercialization of scientifically compelling assets. Its core portfolio is focused on oncology, pulmonary fibrosis and infectious disease. Ocean Biomedical Inc., formerly known as Aesther Healthcare Acquisitions Corp., is...

See More

Key Turning Points

3rd Resistance Point 2.4433
2nd Resistance Point 2.2667
1st Resistance Point 2.0033
Last Price 1.7400
1st Support Level 1.5633
2nd Support Level 1.3867
3rd Support Level 1.1233

See More

52-Week High 12.0800
Fibonacci 61.8% 7.6641
Fibonacci 50% 6.3000
Fibonacci 38.2% 4.9359
Last Price 1.7400
52-Week Low 0.5200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar